Furthermore, a number of genetic mutations, such as LRRK2, PRKN, DJ-1, PINK1, FBXO7 and ATP13A2, in PD patients also provide clues of mitochondrial dysfunction in PD pathogenesis (see below). Here, ATP13A2 is linked to Parkinson disease.